BravoBio Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 150

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 2

BravoBio General Information

Description

Developer of innovative biopharmaceutical human vaccines designed to prevent and treat human infectious diseases. The company offers conjugated vaccine, inhaled COVID-19 vaccine, universal human papilloma vaccine (HPV), varicella zoster vaccine (VZV), RSV vaccine, hexavalent rotavirus vaccine, and universal Sarbecovirus vaccine, and other proprietary vaccines, optimized through optimization design, cell culture optimization, antigen purification, and aseptic filling, thereby helping users in the public and private sector biotechnology field with multifaceted and successful solutions.

Contact Information

Website
www.bravobio.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • BravoBio Technology Park, No. 53 East Qibei Road
  • Baoshan District
  • Shanghai, 201908
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • BravoBio Technology Park, No. 53 East Qibei Road
  • Baoshan District
  • Shanghai, 201908
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BravoBio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BravoBio‘s full profile, request access.

Request a free trial

BravoBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BravoBio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BravoBio‘s full profile, request access.

Request a free trial

BravoBio FAQs

  • When was BravoBio founded?

    BravoBio was founded in 2011.

  • Where is BravoBio headquartered?

    BravoBio is headquartered in Shanghai, China.

  • What is the size of BravoBio?

    BravoBio has 150 total employees.

  • What industry is BravoBio in?

    BravoBio’s primary industry is Drug Discovery.

  • Is BravoBio a private or public company?

    BravoBio is a Private company.

  • What is the current valuation of BravoBio?

    The current valuation of BravoBio is .

  • What is BravoBio’s current revenue?

    The current revenue for BravoBio is .

  • How much funding has BravoBio raised over time?

    BravoBio has raised $37.8M.

  • Who are BravoBio’s investors?

    Beijing Huanan Dingye Investment Management, Jifu Ventures, Jilin Yatai Group Company, Liaoning Chengda, and Shenzhen Qianhai Beizeng are 5 of 6 investors who have invested in BravoBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process